Citation Impact
Citing Papers
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
2015
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells
2013
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop
2013
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
2014
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
2012
Metastatic tumor evolution and organoid modeling implicate TGFBR2as a cancer driver in diffuse gastric cancer
2014
Enhancing Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer: Cotargeting Signaling Pathways
2015
Hepatocellular carcinoma
2016 Standout
Advances and challenges in targeting FGFR signalling in cancer
2017
ROS in cancer therapy: the bright side of the moon
2020 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Hepatocellular carcinoma
2021 Standout
Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model
2003 Standout
Hallmarks of Cellular Senescence
2018 Standout
A call to ARMS: targeting thePAX3-FOXO1gene in alveolar rhabdomyosarcoma
2013
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Cancer-related inflammation and treatment effectiveness
2014 Standout
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Modeling Development and Disease with Organoids
2016 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
FGF Receptors: Cancer Biology and Therapeutics
2013
Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
2013
Role of FGF Receptors as an Emerging Therapeutic Target in Lung Squamous Cell Carcinoma
2013
Works of A. Nigel Brooks being referenced
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
2012
Identification of a possible association between carbon tetrachloride-induced hepatotoxicity and interleukin-8 expression
2000